Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tamoxifen and endometrial cancer.

Literature DB >> 7978932

Tamoxifen and endometrial cancer.

P Sismondi¹, N Biglia, E Volpi, M Giai, T de Grandis.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Tamoxifen

Year: 1994 PMID： 7978932 DOI： 10.1111/j.1749-6632.1994.tb21761.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.

Authors: Monica Milani; Gautam Jha; David A Potter
Journal: Clin Med Ther Date: 2009-03-31

2. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.

Authors: Jason D Wright; Vrunda B Desai; Ling Chen; William M Burke; Ana I Tergas; June Y Hou; Melissa Accordino; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal: Am J Obstet Gynecol Date: 2017-03-21 Impact factor: 8.661

Review 3. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors: Balazs I Bodai; Phillip Tuso
Journal: Perm J Date: 2015

4. Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

Authors: Yoshihiko Ino; Taishi Akimoto; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Asako Ueda; Misaki Ota; Kazufumi Magara; Yohei Tagami; Masaki Murata; Tadashi Hasegawa; Tsuyoshi Saito; Norimasa Sawada; Makoto Osanai
Journal: Histol Histopathol Date: 2019-09-04 Impact factor: 2.303

Tamoxifen and endometrial cancer.

1. Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.

2. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.

Review 3. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

4. Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

5. Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.

Review 6. Tamoxifen and secondary tumours. An update.

7. Has tamoxifen had its day?

Review 8. Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen.

9. Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen.

10. The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer.